Myofascial pain syndrome treatments.
Myofascial pain syndrome (MPS) is a regional pain disorder caused by taut bands of muscle fibers in skeletal muscles called myofascial trigger points. MPS is a common disorder, often diagnosed and treated by physiatrists. Treatment strategies for MPS include exercises, patient education, and trigger point injection. Pharmacologic interventions are also common, and a variety of analgesics, antiinflammatories, antidepressants, and other medications are used in clinical practice. This review explores the various treatment options for MPS, including those therapies that target myofascial trigger points and common secondary symptoms.
Department of Physical Medicine and Rehabilitation, Harvard Medical School, 300 First Avenue, Boston, MA 02129, USA. Electronic address: jborgstein@partners.org.
Joanne
J
Borg-Stein
Department of Physical Medicine and Rehabilitation, Harvard Medical School, 300 First Avenue, Boston, MA 02129, USA.
Mary Alexis
MA
Iaccarino
D015670:Acupuncture Therapy / Q000379:methods; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009209:Myofascial Pain Syndromes / Q000175:diagnosis / Q000628:therapy*; D059408:Pain Management / Q000379:methods*; D026741:Physical Therapy Modalities; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D014147:Tramadol / Q000627:therapeutic use; D004561:Transcutaneous Electric Nerve Stimulation / Q000379:methods; D057968:Transdermal Patch; D016896:Treatment Outcome; D061028:Trigger Points / Q000503:physiopathology*
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009125:Muscle Relaxants, Central; D014147:Tramadol; D008012:Lidocaine
Myofascial pain syndrome; Myofascial trigger points; Pharmacotherapy; Regional muscle pain; Treatment